Mechanism of Lymphocyte-Mediated Cytotoxicity

淋巴细胞介导的细胞毒性机制

基本信息

项目摘要

The granule exocytosis model of lymphocyte-mediated cytotoxicity postulates an antigen-triggered rapid secretion of the preformed potent lytic agent perforin (as well as other mediators) into the synapse-like space between the cytotoxic lymphocyte and its bound target. However, the question of why the effector cell does not itself die of perforin damage has often been raised without a clear answer. We have recently proposed that transiently expressed surface cathepsin B is provides such self protection to cytotoxic T cells and NK cells. Two major lines of evidence support this model: 1) When triggered to degranulate in the presence of membrane impermeant cathepsin B-specific inhibitors, cytotoxic lymphocytes undergo a rapid perforin-dependent, FasL-independent death; 2) A proteolytically active form of cathepsin B is expressed on the surface of cytotoxic T cells after degranulation. Since cathepsin B was previously shown by others to be expressed on the surface of tumor cells, we have tested whether it may be responsible for resisting CTL lethal damage in vitro. A series of in vitro tumor lines was screened to determine if pretreating them with membrane impermeant cathepsin B-specific inhibitors renders them more susceptible to redirected CTL-induced death. Most non-lymphoid tumors seem to be >10x less lysable than lymphoid tumors such as Jurkat after equivalent CTL degranulation. In some cases pre-treatment with CA074 causes a marked increase in lysability. We have seen this behavior with some but not all melanoma and colon tumor cells, and are currently screening a variety of available tumor lines. We previously showed that the cytoplasmic protein Rab27a was required for a late step in granule exocytosis in cytotoxic lymphocytes, but its functional molecular partners remain undefined. We are currently exploring immunoprecipitation-based approaches to identify a putative melanophilin homolog operating in CTL. Cathepsin W is a novel cathepsin originally described as an expressed sequence tag and subsequently found in mRNA expression studies to be expressed exclusively in cytotoxic lymphocytes (both T and NK cells). In order to study the protein and probe its function, we expressed human pre-procathepsin W in E. coli and made a series of monoclonal antibodies against it. In Western blots of CTL, some of these react with a single 25-30kd band, a size expected for active cathepsin W. When these mAb were used to localize cathepsin W, a granular pattern was seen by fluorescence microscopy. We are also examining the expression of granule proteins in naive and memory subpopulations of human blood T lymphocytes phenotypically defined by CCR7 and CD45RO expression. These studies show that memory subsets of both CD4+ and CD8+ express granule markers, which are minimally expressed in naive T cells.
淋巴细胞介导的细胞毒性的颗粒吐出模型假定抗原触发的预形成的有效裂解剂穿孔素(以及其他介质)快速分泌到细胞毒性淋巴细胞与其结合靶细胞之间的突触样间隙中。然而,为什么效应细胞本身不会死于穿孔素损伤的问题经常被提出,但没有明确的答案。我们最近提出,瞬时表达的表面组织蛋白酶B对细胞毒性T细胞和NK细胞具有这样的自我保护作用。支持这一模型的主要证据有两条:1)当在膜上不必要的组织蛋白酶B特异性抑制剂存在的情况下被触发脱颗粒时,细胞毒性淋巴细胞经历快速的穿孔素依赖的、非FasL非依赖的死亡;2)脱颗粒后的细胞毒性T细胞表面表达一种具有蛋白水解性的组织蛋白酶B。由于组织蛋白酶B以前被发现表达在肿瘤细胞表面,我们已经测试了它是否可能在体外抵抗CTL致命性损伤。对一系列体外肿瘤株进行筛选,以确定是否用膜无意义的组织蛋白酶B特异性抑制剂处理它们会使它们更容易受到CTL诱导的重定向死亡的影响。在同等的CTL脱颗粒后,大多数非淋巴样肿瘤的溶解能力似乎比淋巴样肿瘤(如Jurkat)少10倍。在某些情况下,用CA074进行前处理会导致溶解性显着增加。我们已经在一些但不是所有的黑色素瘤和结肠肿瘤细胞中看到了这种行为,目前正在筛选各种可用的肿瘤株。 我们之前的研究表明,细胞毒性淋巴细胞颗粒胞吐的晚期需要胞质蛋白Rab27a,但其功能分子伴侣仍未确定。我们目前正在探索基于免疫沉淀的方法来鉴定CTL中可能存在的亲黑素同源物。 组织蛋白酶W是一种新的组织蛋白酶,最初被描述为一种表达序列标签,后来在mRNA表达研究中发现,它仅在细胞毒淋巴细胞(T细胞和NK细胞)中表达。为了研究该蛋白并探讨其功能,我们在大肠杆菌中表达了人Pre-Proathepsin W,并制备了一系列抗Pre-Prothepsin W的单抗。在CTL的Western blotts中,其中一些细胞与一条25-30kd的条带反应,这是活性组织蛋白W的预期大小。当用这些单抗定位组织蛋白W时,荧光显微镜下可见颗粒状图案。 我们还检测了由CCR7和CD45RO表达所定义的人类血液T淋巴细胞的幼稚和记忆亚群中颗粒蛋白的表达。这些研究表明,CD4+和CD8+的记忆亚群都表达颗粒标记,而颗粒标记在幼稚T细胞中表达最少。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pierre A Henkart其他文献

Pierre A Henkart的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pierre A Henkart', 18)}}的其他基金

Non-cytotoxic functions of lymphocyte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
  • 批准号:
    6948361
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
  • 批准号:
    7292106
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Target Cell Death by Cytotoxic Lymphocytes
细胞毒性淋巴细胞导致的靶细胞死亡
  • 批准号:
    6433137
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Apoptotic Death in T Lymphocytes
T 淋巴细胞凋亡
  • 批准号:
    6433143
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
  • 批准号:
    7070841
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Mechanism of Lymphocyte-Mediated Cytotoxicity
淋巴细胞介导的细胞毒性机制
  • 批准号:
    7048810
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TARGET CELL DEATH BY CYTOTOXIC LYMPHOCYTES
细胞毒性淋巴细胞导致靶细胞死亡
  • 批准号:
    6289235
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
  • 批准号:
    6758411
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Non-cytotoxic functions of lymphoycte granule exocytosis
淋巴细胞颗粒胞吐作用的非细胞毒性功能
  • 批准号:
    6557495
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Apoptotic Death in T Lymphocytes
T 淋巴细胞凋亡
  • 批准号:
    6762145
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了